NorthX Biologics, a leading Nordic biopharmaceutical Contract, Development and Manufacturing Organization, is pleased to announce a significant growth investment from Signet Healthcare Partners, a U.S.-based
An investment of up to $550 million by 2030 will establish the Indianapolis site as a hub for manufacturing of Roche’s continuous glucose monitoring solution. Roche, announced it plans
Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a
The digital mental health company’s strategic growth plans include expanded state coverage and advanced AI-driven care solutions to improve outcomes for families Little Otter, a
Fuel up with free Health Tech Insights
